The most prescribed anti-inflammatory drugs for rheumatoid arthritis ease joint pain and swelling, but don’t stop disease progression, and they don’t work for everyone. Dr. Abdelaziz Amrani and his team at Université de Sherbrooke are developing an innovative new approach to rheumatoid arthritis therapy using dendritic cells genetically engineered to fight inflammation. His research could accelerate a potential immunotherapy for rheumatoid arthritis into clinical trials, thanks in part to your support.

Learn more about Ignite Innovation Grants

Maddie Watts received a life-changing diagnosis of facet joint syndrome – a form of arthritis aggressively attacking her spine at the young age of 17. Now she embraces the dream of joining the 2026 Canadian Paralympic Team. Read Maddie’s story to hear about her journey in the fight against arthritis and how accessing Arthritis Society Canada’s resources and support groups motivated Maddie to pursue higher education, and helped her to ski as much as she can.

Read Maddie’s story

More than 4 million Canadians currently live with osteoarthritis. It has no cure, so current treatments mainly focus on pain relief. Dr. Bruno da Costa and his team performed a critical analysis of clinical evidence on all major nonsurgical treatment approaches for osteoarthritis. Thanks to your support, this research will help doctors and patients choose the best option from the wide array of available treatments for osteoarthritis pain.

Learn more about the breakthroughs